Description

Clinical laboratories are an essential part of the health industry. Approximately 80% of physicians' diagnoses is estimated to be the result of laboratory tests. The constant pressure to reduce healthcare spending is shifting healthcare application in favor of the laboratory, making it a more valuable part of the treatment plan.

Vietnam CLT market is growing at a healthy rate, driven by plans to build new hospitals, upgrade existing public hospitals, and greater budget allocation for lab services. Hence, there are opportunities for clinical labs to grow, as they will attract international players to invest and capitalize on the available opportunities.

Vietnam’s UHC aims to provide health insurance for 80% of its population by 2020. It has covered more than 70% of the population by the end of 2015. The UHC plan targets minority groups and the poor and near-poor population, providing the highest possible coverage. In addition to basic hospital fees, the plan covers medicine, testing, and a large portion of hospital fees for cancer patients.

As the private sector continues to attract the affluent population, the demand for screening of infectious diseases will rise. It will fuel growth of routine and specialized tests. Key opportunities for future in the market include clinical test outsourcing to independent labs. There are opportunities for private independent labs to grow, as the government is keen on public-private partnerships to ease the burden on its healthcare infrastructure by providing healthcare coverage that can make private healthcare more accessible. Opportunities also exist to meet healthcare demands outside Vietnam's major cities, where hospitals and lab services are not saturated. Thus, this report will help key players in the industry to better understand market-entrant opportunities. There are opportunities for private independent labs to grow, as the government is keen on
public-private partnerships to ease the burden on its healthcare infrastructure by providing healthcare coverage that can make private healthcare more accessible. Despite these efforts, patients are skeptical of private healthcare quality, as many labs are not accredited.